Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genotypic Technology is an India-based genomics and bioinformatics company that provides commercial sequencing, microarray, bioinformatics, and related research services to pharma, biotech, diagnostics, and academic customers. Founded in 1998, the company positions itself as India’s first genomics company and operates a high-throughput genomics facility in Bengaluru. Its offerings span next-generation sequencing, long-read sequencing through Oxford Nanopore partnership channels, targeted panels, genomics compute infrastructure, and user-friendly NGS data analysis software. Genotypic also conducts internal R&D in human healthcare and agricultural genomics, including targeted resequencing panels and sequencing-based assays for clinical trials and drug discovery. In addition, the company expanded into diagnostics in 2020 with testing solutions covering infectious diseases such as COVID-19, malaria, HIV, syphilis, and hepatitis C.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genotypic Technology.